Arrowhead Pharmaceuticals
ARWR
#3792
Rank
$2.64 B
Marketcap
$20.96
Share price
-0.57%
Change (1 day)
-28.27%
Change (1 year)

P/S ratio for Arrowhead Pharmaceuticals (ARWR)

P/S ratio as of February 2025 (TTM): > 1000

According to Arrowhead Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 47.1. At the end of 2024 the company had a P/S ratio of 944.

P/S ratio history for Arrowhead Pharmaceuticals from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20249445117.14%
202318.19.07%
202216.6-65.44%
202148.0-51.41%
202098.8151.89%
201939.261.22%
201824.3169.8%
20179.01-64.88%
201625.7-98.22%
2015> 10007.55%
2014> 1000-44.71%
2013> 10001936.39%
2012119-93.55%
2011> 100012700.49%
201014.439.13%
200910.3-57.95%
200824.6-72.88%
200790.6-78.6%
2006424111.8%
20052006.9%
2004187547.7%
200328.9126.56%
200212.7-11.98%
200114.5

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
14.5-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
15.1-98.57%๐Ÿ‡บ๐Ÿ‡ธ USA
394-62.73%๐Ÿ‡บ๐Ÿ‡ธ USA
4.33-99.59%๐Ÿ‡บ๐Ÿ‡ธ USA
2.57-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA